Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Integra Lifesciences Holdings Corp shares valued at $995,816 were purchased by HILL BARBARA B on May 21 ’24. At $27.40 per share, HILL BARBARA B acquired 36,350 shares. The insider’s holdings grew to 36,350 shares worth approximately $1.02 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, DAVIS ROBERT T. JR. sold 8,348 shares, netting a total of over 305,492 in proceeds. Following the sale of shares at $36.59 each, the insider now holds 49,893 shares.
Before that, Mosebrook Jeffrey had sold 1,177 shares from its account. In a trade valued at $52,329, the SVP, Fin & PAO traded Integra Lifesciences Holdings Corp shares for $44.46 each. Upon closing the transaction, the insider’s holdings decreased to 1,177 shares, worth approximately $0.66 million.
As published in a research note from Wells Fargo on May 07, 2024, Integra Lifesciences Holdings Corp [IART] has been rated down from an Overweight to an Equal weight and the price target has been revised to $25 from $45. Analysts at Oppenheimer downgraded the stock from ‘”an Outperform”‘ to ‘”a Perform”‘ outlook in a report released in early May. As of April 03, 2024, Citigroup has increased its “Sell” rating to a “Neutral” for IART. Earlier on December 05, 2023, Wells Fargo upgraded its rating. Their new recommendation was “an Overweight” for IART stock which previously was a “an Equal weight”.
Analyzing IART Stock Performance
During the last five days, there has been a surge of approximately 6.23%. Over the course of the year, Integra Lifesciences Holdings Corp shares have dropped approximately -35.43%. Shares of the company reached a 52-week high of $45.42 on 02/20/24 and a 52-week low of $22.36 on 05/06/24. A 50-day SMA is recorded $30.79, while a 200-day SMA reached $38.02. Nevertheless, trading volume fell to 0.9 million shares from 2.6 million shares the previous day.
Support And Resistance Levels for Integra Lifesciences Holdings Corp (IART)
According to the 24-hour chart, there is a support level at 27.50, which, if violated, would cause prices to drop to 26.87. In the upper region, resistance lies at 28.53. The next price resistance is at 28.93. RSI (Relative Strength Index) is 48.50 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.07, which suggests the price will increase in the coming days. Percent R is at 21.95%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
